Drug Firm Lupin Ltd announced today that its subsidiary Lupin Pharmaceuticals has received approval from the United States Food and Drugs Administration (US FDA) for its Oral suspension – Suprax in the strength of 500mg/5mL. The company expects to start shipping the product in near future. Presently Suprax is available as 100 mg/5ml and 200 […]
Continue Reading...
